VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
NCT ID: NCT06570889
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
2000 participants
INTERVENTIONAL
2024-12-20
2033-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood
NCT00856947
High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children
NCT05043116
Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)
NCT02687815
Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)
NCT00920621
Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children
NCT02046577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 (cholecalciferol) 3200 IU/day
Oral intake of 1 capsule daily from week 22-26 of gestation until 1 week after delivery
Cholecalciferol D3
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Placebo Pearls with olive oil
Oral intake of 1 capsule daily from week 22-26 of gestation until 1 week after delivery
Olive oil
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cholecalciferol D3
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Olive oil
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No current vitamin D intake above the recommended 400 IU/day
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Professor Klaus Bønnelykke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Klaus Bønnelykke
Professor PhD, Head of COPSAC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Bønnelykke, PhD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Studies on Asthma in Childhood
Bo Chawes, PhD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Studies on Asthma in Childhood
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital of Copenhagen
Gentofte Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Brustad N, Vahman N, Ralfkiaer U, Mikkelsen M, Brandt S, Kyvsgaard JN, Vinding R, Stokholm J, Chawes B, Bonnelykke K. Fish oil and vitamin D in pregnancy for the prevention of early childhood asthma: study protocol for two double-blinded, randomised controlled trials. BMJ Open. 2024 Dec 31;14(12):e092902. doi: 10.1136/bmjopen-2024-092902.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-23055833-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.